Perkinelmer Inc. is aiming to boost its infectious disease testing footprint with the acquisition of Oxford Immunotec Global plc for $591 million in cash. The purchase, reported Thursday, will allow Perkinelmer to expand its current offerings with solutions for tuberculosis (TB) detection. Perkinelmer shares (NYSE:PKI) hit a high of $162.16 Thursday morning, before closing at $160.53 – up 2.66% from the Wednesday’s close of $156.37. Read More

Just a week into 2021 and Hologic Inc. is planning another acquisition. The company announced that it has agreed to acquire the molecular diagnostics testing company Biotheranostics Inc. for roughly $230 million cash up front. This comes on the heels of completing the acquisition of Somatex Medical Technologies GmbH for about $64 million. The acquisition of San Diego-based Biotheranostics is expected to close in February 2021, pending antitrust clearance. Read More

Ablacon Inc. has revealed the close of a $30 million series B financing, with Zeus Health joining as new lead investor. The company intends to use the funds to advance its product portfolio and expand patient access to the Ablamap system, which has the CE mark. Read More

Computer system validation (CSV) has been the source of considerable drag on device makers’ efforts to realize value derived from investments in the company’s technology base, but this long-standing issue is finally drawing some much-needed attention. Read More

Ultromics Ltd. received U.S. FDA 510(k) clearance for its artificial intelligence-driven decision support tool for the diagnosis of coronary artery disease (CAD). Used in conjunction with a clinician's assessment, Echogo Pro's algorithms improve disease prediction and support more accurate diagnosis. Echogo Pro is a stress-Echo module in the Oxford, U.K.-based company's Echogo suite for CAD diagnosis. Read More

New hires and promotions in the med-tech industry, including: Dariohealth, Gen Incode, Ibex Medical Analytics, Neuroone, Paragon 28, Si-Bone, T2 Biosystems. Read More

Med-tech firms raising money in public or private financings, including: Adeptrix, Cathworks, Dermtech, Neogenomics, Neuros Medical. Read More

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Immunovia. Read More

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Amptec, Agimed, Apt Medical, Avacta, Caredx, Cellectis, Clear Labs, Daavlin, Ehave, Foracare Suisse, Freedom Ventures, Haliodx, Healthmyne, IDbyDNA, Idt, Immunovia, Infab, Konica Minolta Healthcare, Medallia, Medidrapes, Merck, Milliporesigma, Mirion Technologies, Neuros Medical, Nuvo Group, OncoDNA, Pi-Cardia, Point Biopharma, QT Imaging, Reflexion Medical, Sirion Biotech, Skylight Health Group, Soligenix, Solvd Health, Spectrum Solutions, Steribottle, Sun Nuclear, Theralight, Tidepool, Twist Bioscience, Vericel, Unitedhealthcare. Read More

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Cardiowise, Locate Bio, Siemens Healthineers. Read More

The latest global regulatory news, changes and updates affecting medical devices and technologies, including: HHS unveils $22B testing fund; Trade associations sound off on Capitol Hill pandemonium; FDA reopens recall docket; Health care bills become U.S. law. Read More

Keeping you up to date on recent developments in diagnostics, including: Retinal imaging may detect Parkinson’s disease; Biomarkers may differentiate psoriatic arthritis, osteoarthritis; ApoE multitasks for regulating brain lipids. Read More